During the past decade, Spectrum Health Medical Group conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spectrum Health Medical Group" #1 sponsor was "United Therapeutics" with 4 trials, followed by "Anchiano Therapeutics Israel Ltd." with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spectrum Health Medical Group" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "FKD Therapies Oy" with 1 trials as a collaborator, "Mayo Clinic" with 1 trials as a collaborator and "Medical University of Graz" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Spectrum Health Medical Group" are "Pulmonary Hypertension" (3 trials), "Bladder Cancer" (2 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials) and "Familial Primary Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "Spectrum Health Medical Group" in a lesser frequency.

Most popular intervention types in "Spectrum Health Medical Group" are "Drug" (10 trials), "Behavioral" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Oral treprostinil" (2 trials), "Ralinepag" (2 trials), "ADSTILADRIN" (1 trials) and "Apaziquone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spectrum Health Medical Group" are 15 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Spectrum Health Medical Group". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Spectrum Health Medical Group, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Spectrum Health Medical Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".